Clinical Trial Update: BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM

View source ↗

Summary

Post-market BMX Alpha Registry is monitoring outcomes in patients with coronary disease and ischemic conditions after BioMatrix Alpha stent deployment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Ischemia
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction
• Stable Angina

Drugs mentioned

• BioMatrix Alpha (BioMatrix Alpha stent)

Snippet

Sponsor: Biosensors Europe SA | Conditions: Coronary Artery Disease, Stable Angina | Status: UNKNOWN